MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Pliant Therapeutics, Inc. Common Stock

PLRX

#3339
Pliant Therapeutics, Inc. Common Stock
1.30
+3.17%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
1.30
1.30
Intervallo Annuale
1.09
3.46
Variazione giornaliera
+3.17%
Variazione Mensile
+4.00%
Variazione di 6 mesi
-23.08%
Variazione Annuale
-59.25%
Chiusura Precedente
1.26
Open
1.30
Bid
Ask
Low
1.30
High
1.30
Volume
7
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. PLRX
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Notizie

Seeking Alpha Seeking Alpha
PLRX
2026.02.24
Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
Investing Investing
PLRX
2026.01.23
Il CFO di Pliant Therapeutics Cummings vende azioni per $30.722
Investing Investing
PLRX
2026.01.23
Il CHRO di Pliant Therapeutics Cheung vende titoli per 9.600 dollari
Investing Investing
PLRX
2026.01.23
Pliant therapeutics CFO Cummings sells $30,722 in stock
Investing Investing
PLRX
2026.01.23
Pliant Therapeutics CHRO Cheung sells $9.6k in stock
Investing Investing
PLRX
2026.01.23
Il COO di Pliant Therapeutics Minnie Kuo vende azioni per $8.853
Investing Investing
PLRX
2025.12.16
Pliant Therapeutics nomina Minnie Kuo come chief operating officer
Investing Investing
PLRX
2025.12.16
Pliant Therapeutics appoints Minnie Kuo as chief operating officer
Seeking Alpha Seeking Alpha
PLRX
2025.12.09
Pliant Therapeutics, Inc. (PLRX) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:PLRX) 2025-12-09
Investing Investing
PLRX
2025.12.08
Pliant Therapeutics porrà fine al rapporto di lavoro del direttore medico Dr. Éric Lefebvre
Investing Investing
PLRX
2025.12.08
Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre
Investing Investing
PLRX
2025.12.04
Pliant Therapeutics stock jumps on promising cancer drug trial results

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd